Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
Kyoung Min Kim, Yumie Rhee, Yong-Dae Kwon, Tae-Geon Kwon, Jeong Keun Lee, Deog-Yoon Kim
J Bone Metab. 2015;22(4):151-165.   Published online 2015 Nov 30     DOI: https://doi.org/10.11005/jbm.2015.22.4.151
Citations to this article as recorded by Crossref logo
Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner
Ryohei Kozutsumi, Shinichiro Kuroshima, Haruka Kaneko, Muneteru Sasaki, Akira Ishisaki, Takashi Sawase
Calcified Tissue International.2022; 110(1): 104.     CrossRef
Extensive surgery in medication‐related osteonecrosis of the jaw for the prevention of infective endocarditis
Takashi Narai, Takayuki Tamura, Nobuyuki Fujii, Yusei Harada, Soh Watanabe, Isamu Kodani
Oral Science International.2022; 19(2): 101.     CrossRef
Prognosis of Medication-Related Osteonecrosis of the Jaw with Surgical Treatment
Eizaburo Kobayashi, Haruka Takahashi, Kensuke Igarashi, Hiroki Katagiri, Maiko Haga-Tsujimura, Ichiro Ogura, Ken Nakahara, Akira Tanaka
Journal of Hard Tissue Biology.2022; 31(1): 39.     CrossRef
DEVELOPMENT OF INFORMED VOLUNTARY CONSENT FOR VARIOUS TYPES OF DENTAL INTERVENTIONS FOR PATIENTS TAKING ANTIRESORPTIVE DRUGS
Elena Spevak, Dmitry Christoforando, Grigoriy Sazanov, Anna Cymbal
Actual problems in dentistry.2022; 17(4): 151.     CrossRef
Medication-related osteonecrosis of the jaw: An update
Hitesh Bansal
National Journal of Maxillofacial Surgery.2022; 13(1): 5.     CrossRef
Medication-Related Osteonecrosis of the Jaws: A Literature Review
Gyeong-Mi Kim, Seong-Yong Moon, Jae-Seek You, Gyeong-Yun Kim, Ji-Su Oh
Journal of Oral Medicine and Pain.2022; 47(1): 1.     CrossRef
Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing
Songmi Kim, Seyoung Mun, Wonseok Shin, Kyudong Han, Moon-Young Kim
Journal of Clinical Medicine.2022; 11(8): 2145.     CrossRef
Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents
Yehuda Zadik, Yotam Ganor, Ori Rimon, Evgeniya Bersudski, Amichay Meirovitz
Radiotherapy and Oncology.2021; 156: 275.     CrossRef
Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series
Guillermo Pardo-Zamora, Yanet Martínez, Jose Antonio Moreno, Antonio J. Ortiz-Ruíz
International Journal of Environmental Research and Public Health.2021; 18(3): 1018.     CrossRef
Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score‐matched study
Jae‐In Ryu, Ha‐Young Kim, Yong‐Dae Kwon
Clinical Oral Implants Research.2021; 32(4): 437.     CrossRef
A critical assessment of the medication-related osteonecrosis of the jaw classification in stage I patients: a retrospective analysis
Oliver Ristow, Lena Hürtgen, Julius Moratin, Maximilian Smielowski, Christian Freudlsperger, Michael Engel, Jürgen Hoffmann, Thomas Rückschloß
Journal of the Korean Association of Oral and Maxillofacial Surgeons.2021; 47(2): 99.     CrossRef
Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review
Mampei Kawahara, Shinichiro Kuroshima, Takashi Sawase
International Journal of Implant Dentistry.2021;[Epub]     CrossRef
Inhibiteurs de la résorption osseuse et risque d’ostéonécrose des mâchoires (ONM)
Benjamin Salmon, Nathan Moreau, Thomas Funck-Brentano
Revue du Rhumatisme Monographies.2021; 88(4): 298.     CrossRef
Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice
Worakanya Buranaphatthana, Apichai Yavirach, Elizabeth M. Leaf, Marta Scatena, Hai Zhang, Jonathan Y. An, Cecilia M. Giachelli
Bone.2021; 153: 116144.     CrossRef
Investigation of the Effectiveness of Surgical Treatment on Maxillary Medication-Related Osteonecrosis of the Jaw: A Literature Review
Kun-Jung Hsu, Szu-Yu Hsiao, Ping-Ho Chen, Han-Sheng Chen, Chun-Ming Chen
Journal of Clinical Medicine.2021; 10(19): 4480.     CrossRef
18 Years of Medication-Related Osteonecrosis of the Jaw (MRONJ) Research: Where Are We Now?—An Umbrella Review
Roberto Sacco, Monica Diuana Calasans-Maia, Julian Woolley, Oladapo Akintola, Carlos Fernando de Almeida Barros Mourão, Vittorio Moraschini, Evgeny Kushnerev, Alessandro Acocella, Olamide Obisesan, Julian Yates
Applied Sciences.2021; 11(19): 8818.     CrossRef
Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review
Alejandro I. Lorenzo-Pouso, José Bagán, Leticia Bagán, Pilar Gándara-Vila, Cintia M. Chamorro-Petronacci, Pablo Castelo-Baz, Andrés Blanco-Carrión, María Ángeles Blanco-Fernández, Óscar Álvarez-Calderón, Javier Carballo, Mario Pérez-Sayáns
Journal of Clinical Medicine.2021; 10(19): 4367.     CrossRef
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
Ha Young Kim
Endocrinology and Metabolism.2021; 36(5): 917.     CrossRef
Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis
Jung-Hyun Park, Min-Jeong Kwoen, Jae-Ryun Lee, Keun-Suh Kim, Hyo-Jung Lee, Jin-Woo Kim, Hyejin Lee
Frontiers in Endocrinology.2021;[Epub]     CrossRef
Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
Jin-Woo Kim, Mi Kyung Kwak, Jeong Joon Han, Sung-Tak Lee, Ha Young Kim, Se Hwa Kim, Junho Jung, Jeong Keun Lee, Young-Kyun Lee, Yong-Dae Kwon, Deog-Yoon Kim
Journal of Bone Metabolism.2021; 28(4): 279.     CrossRef
Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
Camilla Ottesen, Morten Schiodt, Klaus Gotfredsen
Heliyon.2020; 6(4): e03795.     CrossRef
Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors
Jason T. Wan, Douglas M. Sheeley, Martha J. Somerman, Janice S. Lee
Bone Research.2020;[Epub]     CrossRef
Therapeutic approach and management algorithms in medication-related osteonecrosis of the jaw (MONJ): recommendations of a multidisciplinary group of experts
Monique Chalem, Adriana Medina, Ana Karina Sarmiento, Deyanira Gonzalez, Carlos Olarte, Edgar Pinilla, Jorge Paz, Noemi Casas, Maria Paula Vega, Edna Diaz
Archives of Osteoporosis.2020;[Epub]     CrossRef
Dentists' knowledge about medication-related osteonecrosis of the jaw and its management
R. Al-Eid, T. Alduwayan, M. Bin Khuthaylah, M. Al Shemali
Heliyon.2020; 6(7): e04321.     CrossRef
Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study
Na Rae Choi, Jung Han Lee, Jin Young Park, Dae Seok Hwang
International Journal of Environmental Research and Public Health.2020; 17(23): 8801.     CrossRef
Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology
Antonio Fabrizio Nifosì, Mariateresa Zuccarello, Lorenzo Nifosì, Vanessa Hervas Saus, Gianfilippo Nifosì
Journal of the Korean Association of Oral and Maxillofacial Surgeons.2019; 45(1): 3.     CrossRef
Dental care for patients taking antiresorptive drugs: a literature review
Minju Song
Restorative Dentistry & Endodontics.2019;[Epub]     CrossRef
Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw
Matthias Zirk, Charlotte Wenzel, Johannes Buller, Joachim E. Zöller, Max Zinser, Franziska Peters
Clinical Oral Investigations.2019; 23(5): 2143.     CrossRef
Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
Daniel Amaral Alves MARLIÉRE, Tony Eduardo COSTA, Rafael Binato JUNQUEIRA, Saulo de Matos BARBOSA, Luciana ASPRINO, Henrique Duque de Miranda CHAVES NETTO
RGO - Revista Gaúcha de Odontologia.2019;[Epub]     CrossRef
Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletons
Jorge William Vargas-Franco, Beatriz Castaneda, Andrea Gama, Christopher G. Mueller, Dominique Heymann, Françoise Rédini, Frédéric Lézot
Biochemical Pharmacology.2019; 168: 133.     CrossRef
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
Noam Yarom, Charles L. Shapiro, Douglas E. Peterson, Catherine H. Van Poznak, Kari Bohlke, Salvatore L. Ruggiero, Cesar A. Migliorati, Aliya Khan, Archie Morrison, Holly Anderson, Barbara A. Murphy, Devena Alston-Johnson, Rui Amaral Mendes, Beth Michelle
Journal of Clinical Oncology.2019; 37(25): 2270.     CrossRef
Usability of Surgical Treatment of Stage Ⅱ Medication Related Osteonecrosis of the Jaw
Dae-Seok Hwang, Jae-Min Song, Mi-Heon Ryu, Na-Rae Choi
The Korean Journal of Oral and Maxillofacial Pathology.2019; 43(1): 17.     CrossRef
Three-dimensional bone evaluation after surgical treatment with plasma rich in growth factors of Medication Related Osteonecrosis of the Jaw (MRONJ): A report of 3 cases
Simón Pardiñas López, Oreste Iocca, Ismael Khouly
Bone Reports.2019; 10: 100208.     CrossRef
Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw
Mong-Hun Kang, Dong-Keon Lee, Chang-Woo Kim, In-Seok Song, Sang-Ho Jun
Journal of the Korean Association of Oral and Maxillofacial Surgeons.2018; 44(5): 225.     CrossRef
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer
Morten Schiodt, Saroj Vadhan-Raj, Mark S. Chambers, Ourania Nicolatou-Galitis, Constantinus Politis, Ruxandra Coropciuc, Stefano Fedele, Danielle Jandial, Jeffrey Zhang, Haijun Ma, Deborah P. Saunders
Supportive Care in Cancer.2018; 26(6): 1905.     CrossRef
Medical Treatment of Osteoporosis/Prevention of Falls
Hyoung Keun Oh
Journal of the Korean Fracture Society.2018; 31(4): 165.     CrossRef
Otorhinolaryngological Toxicities of New Drugs in Oncology
Dana M. Hartl, Daphné Morel, Erika Saavedra, Christophe Massard, Alessandra Rinaldo, Nabil F. Saba, Alfio Ferlito, Jean-Charles Soria
Advances in Therapy.2017; 34(4): 866.     CrossRef
In-vivo imaging of the microvasculature of the soft tissue margins of osteonecrotic jaw lesions
P. Bastos, V. Patel, F. Festy, N. Hosny, R. J. Cook
British Dental Journal.2017; 223(9): 699.     CrossRef
Hyperbaric oxygen therapy and osteonecrosis
P Ceponis, C Keilman, C Guerry, JJ Freiberger
Oral Diseases.2017; 23(2): 141.     CrossRef
Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites
Cornelio Blus, Giulio Giannelli, Serge Szmukler-Moncler, Germano Orru
Oral and Maxillofacial Surgery.2017; 21(1): 41.     CrossRef
Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw
Toshiyuki Yoneda, Hiroshi Hagino, Toshitsugu Sugimoto, Hiroaki Ohta, Shunji Takahashi, Satoshi Soen, Akira Taguchi, Toshihiko Nagata, Masahiro Urade, Takahiko Shibahara, Satoru Toyosawa
Journal of Bone and Mineral Metabolism.2017; 35(1): 6.     CrossRef
Pharmacologic treatment of osteoporosis
Yong-Ki Min
Journal of the Korean Medical Association.2016; 59(11): 847.     CrossRef
Management of osteoporosis patients for prosthetic restoration
Ji-Yeon Baek, Han-Sol Jeon, Jin-Han Lee
Journal of Dental Rehabilitation and Applied Science.2016; 32(2): 93.     CrossRef
Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico
María Verónica Cuevas-González, Celia Minerva Díaz-Aguirre, Enrique Echevarría-y-Pérez, Juan Carlos Cuevas-González
Journal of the Korean Association of Oral and Maxillofacial Surgeons.2016; 42(6): 365.     CrossRef